These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 6692435)

  • 1. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of the report of the 1966 Cancer Chemotherapy Collaborative Program Review Committee.
    Richardson AP
    Cancer Treat Rep; 1984 Jan; 68(1):340-1. PubMed ID: 6692434
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer research program strategy and planning--the use of contracts for program implementation.
    Baker CG
    J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):651-69. PubMed ID: 328910
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 5. Origins and development of chemotherapy research at the National Cancer Institute.
    Zubrod CG
    Cancer Treat Rep; 1984 Jan; 68(1):9-19. PubMed ID: 6362871
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD; Greenwald P
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract]   [Full Text] [Related]  

  • 7. Urologic cancer research at the National Cancer Institute.
    Chiarodo A
    Semin Urol; 1993 Feb; 11(1):2-6. PubMed ID: 8465123
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrasting viewpoints on cancer drug development: the Wooldridge and Richardson reports.
    DeVita VT
    Cancer Treat Rep; 1984 Jan; 68(1):339-40. PubMed ID: 6692433
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer problems lead list for potential medical marijuana research studies.
    Smigel K
    J Natl Cancer Inst; 1997 Sep; 89(17):1255. PubMed ID: 9293912
    [No Abstract]   [Full Text] [Related]  

  • 10. Intramural research and training at NINR.
    Grady PA
    Nurs Outlook; 2007; 55(4):208-9. PubMed ID: 17678687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Address presented at the dedication of the R. A. Bloch International Cancer Information Center, Bethesda, Maryland, October 2, 1983.
    Brandt EN
    Cancer Treat Rep; 1984 Jan; 68(1):5-7. PubMed ID: 6692437
    [No Abstract]   [Full Text] [Related]  

  • 12. The National Cancer Program, 1971--1976.
    Newell GR
    Prog Clin Cancer; 1978; 7():1-10. PubMed ID: 704880
    [No Abstract]   [Full Text] [Related]  

  • 13. Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.
    Carter SK; Slavik M
    Natl Cancer Inst Monogr; 1977 Mar; (45):101-21. PubMed ID: 73134
    [No Abstract]   [Full Text] [Related]  

  • 14. An open letter to cancer researchers.
    Elledge SJ; Hannon GJ
    Science; 2005 Oct; 310(5747):439-41. PubMed ID: 16239460
    [No Abstract]   [Full Text] [Related]  

  • 15. History of the National Cancer Institute and the plant screening program.
    Schepartz SA
    Cancer Treat Rep; 1976 Aug; 60(8):975-7. PubMed ID: 791487
    [No Abstract]   [Full Text] [Related]  

  • 16. The National Institute of General Medical Sciences.
    Becker GJ
    J Am Coll Radiol; 2005 Sep; 2(9):790-2. PubMed ID: 17411928
    [No Abstract]   [Full Text] [Related]  

  • 17. National Cancer Institute helps businesses cross 'the valley of death'.
    Nair P
    Nat Med; 2008 Aug; 14(8):795. PubMed ID: 18685581
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov; 44(11):721-3. PubMed ID: 7226778
    [No Abstract]   [Full Text] [Related]  

  • 20. The Organ Site Programs and the National Cancer Program.
    King TJ
    Cancer Res; 1977 Aug; 37(8 Pt 2):2743-4. PubMed ID: 872100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.